| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Deepak Cyril D'Souza, Marta DiForti, Suhas Ganesh, Tony P George, Wayne Hall, Carsten Hjorthøj, Oliver Howes, Matcheri Keshavan, Robin M Murray, Timothy B Nguyen, Godfrey D Pearlson, Mohini Ranganathan, Alex Selloni, Nadia Solowij, Edoardo Spinazzol. Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry. 2022-03-22. PMID:35315315. |
consensus paper of the wfsbp task force on cannabis, cannabinoids and psychosis. |
2022-03-22 |
2023-08-13 |
Not clear |
| Sarah Lord, Janet Hardy, Phillip Goo. Does Cannabidiol Have a Benefit as a Supportive Care Drug in Cancer? Current treatment options in oncology. 2022-03-22. PMID:35316478. |
focus has fallen on cannabidiol (cbd) as a potential treatment for a variety of symptoms in advanced cancer due to the lack of psychoactive side effects and the potential molecular mechanisms of action associated with this cannabinoid. |
2022-03-22 |
2023-08-13 |
Not clear |
| Guillermo Burillo-Putze, John R Richards, Consuelo Rodríguez-Jiménez, Alejandro Sanchez-Agüer. Pharmacological management of cannabinoid hyperemesis syndrome: an update of the clinical literature. Expert opinion on pharmacotherapy. 2022-03-21. PMID:35311429. |
cannabinoid hyperemesis syndrome (chs) is an uncommon but unique disorder defined by recurrent abdominal pain, intractable nausea, and emesis in patients who regularly smoke cannabis. |
2022-03-21 |
2023-08-13 |
Not clear |
| Katherine Walukevich-Dienst, Paige E Morris, Raymond P Tucker, Amy L Copeland, Julia D Buckne. Development and initial psychometric properties of the Cannabidiol Outcome Expectancies Questionnaire (CBD-OEQ). Psychological assessment. 2022-03-17. PMID:35298216. |
cannabidiol (cbd), a nonpsychoactive cannabinoid, is used by many individuals to treat medical and mental health conditions, despite limited support for the efficacy of cbd for these conditions. |
2022-03-17 |
2023-08-13 |
Not clear |
| Escarlin Perez, Jasmin Ceja-Vega, Michael Krmic, Alondra Gamez Hernandez, Jamie Gudyka, Riley Porteus, Sunghee Le. Differential Interaction of Cannabidiol with Biomembranes Dependent on Cholesterol Concentration. ACS chemical neuroscience. 2022-03-17. PMID:35298887. |
cannabidiol (cbd), the major nonpsychoactive component of plant-derived cannabinoids, has been reported to have a broad range of potential beneficial pharmacological effects on the central nervous system (cns). |
2022-03-17 |
2023-08-13 |
Not clear |
| Jami D Reber, Erin L Karschner, Joshua Z Seither, Jessica L Knittel, Katherine V Dozier, Jeffrey P Walterschei. An Enhanced LC-MS/MS Technique for Distinguishing Δ8- and Δ9-Tetrahydrocannabinol Isomers in Blood and Urine Specimens. Journal of analytical toxicology. 2022-03-10. PMID:35265983. |
among the abundance of cannabinoids identified in cannabis, the active parent drug, Δ9-tetrahydrocannabinol (Δ9-thc), and its oxidized metabolite, 11-nor-9-carboxy-Δ9-thc (Δ9-thccooh), are attractive analytical targets to detect cannabis use. |
2022-03-10 |
2023-08-13 |
Not clear |
| Eve M O'Reilly, Joanne M Cosgrave, William M Gallagher, Antoinette S Perr. Plant-derived cannabinoids as anticancer agents. Trends in cancer. 2022-03-09. PMID:35260379. |
substantial preclinical evidence demonstrates the antiproliferative, cytotoxic, and antimetastatic properties of plant-derived cannabinoids (phytocannabinoids) such as cannabidiol and tetrahydrocannabinol. |
2022-03-09 |
2023-08-13 |
Not clear |
| Svante Vikingsson, Ruth E Winecker, Edward J Cone, David J Kuntz, Brian Dorsey, Martin Jacques, Melanie Senter, Ronald R Flegel, Eugene D Haye. Prevalence of Cannabidiol, Δ9- and Δ8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Journal of analytical toxicology. 2022-03-09. PMID:35260906. |
given the recent popularity of cannabidiol (cbd) use and the emergence of Δ8-tetrahydrocannabinol (Δ8-thc), the prevalence and concentration of these and other cannabinoids was investigated in 2,000 regulated and 4,000 non-regulated specimens from workplace drug testing. |
2022-03-09 |
2023-08-13 |
Not clear |
| Svante Vikingsson, Ruth E Winecker, Edward J Cone, David J Kuntz, Brian Dorsey, Martin Jacques, Melanie Senter, Ronald R Flegel, Eugene D Haye. Prevalence of Cannabidiol, Δ9- and Δ8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens. Journal of analytical toxicology. 2022-03-09. PMID:35260906. |
parent Δ8-thc is a minor cannabinoid in marijuana, which appears to account for the typically low Δ8-thc-cooh concentrations (median 3.4 ng/ml) in most positive specimens. |
2022-03-09 |
2023-08-13 |
Not clear |
| Caroline Figueira Pereira, Divane de Vargas, Fernanda Lima Toneloto, Victor Daichi Ito, Rosa Jacinto Volpat. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review. Revista brasileira de enfermagem. vol 75Suppl 1. issue Suppl 1. 2022-03-09. PMID:35262598. |
implications of cannabis and cannabinoid use in covid-19: scoping review. |
2022-03-09 |
2023-08-13 |
Not clear |
| Caroline Figueira Pereira, Divane de Vargas, Fernanda Lima Toneloto, Victor Daichi Ito, Rosa Jacinto Volpat. Implications of Cannabis and Cannabinoid Use in COVID-19: Scoping Review. Revista brasileira de enfermagem. vol 75Suppl 1. issue Suppl 1. 2022-03-09. PMID:35262598. |
to identify and synthesize studies on the effects of cannabis use and its relation with sars-cov-2, as well as the therapeutic possibilities of using cannabinoids in the prevention and treatment of covid-19. |
2022-03-09 |
2023-08-13 |
Not clear |
| Adeyinka Adeniyi, Sandra Abadir, Mohammed Kooshkabadi, Sunday O Yusuf, Radhika Khanna, Biagio Collura, Marie Anais Hichar. Recreational Marijuana Use and Coronary Artery Dissection: A Case Series. Cureus. vol 14. issue 1. 2022-03-07. PMID:35251848. |
adverse cardiovascular consequences of recreational use of marijuana and synthetic cannabinoids include stroke, artery dissection, vasospasm, vasculitis, coronary artery thrombosis, myocarditis/pericarditis, postural hypotension, arrhythmias, and acute heart failure. |
2022-03-07 |
2023-08-13 |
Not clear |
| Kara Amstutz, Wayne S Schwark, Alexander Zakharov, Beatriz Gomez, Alex Lyubimov, Karolynn Ellis, Kurt P Venator, Joseph J Wakshla. Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation. Journal of veterinary pharmacology and therapeutics. 2022-03-05. PMID:35246858. |
the use of cannabinoids in veterinary medicine has been increasing exponentially recently and there is little information regarding the pharmacokinetics of cannabinoids except for cannabidiol (cbd) and tetrahydrocannabinol (thc), with even more sparse information related to their native acid forms found in cannabis. |
2022-03-05 |
2023-08-13 |
Not clear |
| Kara Amstutz, Wayne S Schwark, Alexander Zakharov, Beatriz Gomez, Alex Lyubimov, Karolynn Ellis, Kurt P Venator, Joseph J Wakshla. Single dose and chronic oral administration of cannabigerol and cannabigerolic acid-rich hemp extract in fed and fasted dogs: Physiological effect and pharmacokinetic evaluation. Journal of veterinary pharmacology and therapeutics. 2022-03-05. PMID:35246858. |
cannabigerol (cbg) is the precursor molecule to cannabinoid formation in the cannabis plant which may have medicinal properties as well, yet there are no publications related to cbg or the native cannabigerolic acid (cbga) in companion animal species. |
2022-03-05 |
2023-08-13 |
Not clear |
| Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, Anna Garmpi, Evangelos Diamantis, Panagiotis Sarantis, Vasiliki E Georgakopoulou, Alexandros Patsouras, Dionysios Prevezanos, Athanasios Syllaios, Georgios Kyriakos, Evangelos Koustas, Markos Despotidis, Christos Vallilas, Petros Papalexis, Efstathios A Antoniou, Konstantinos Kontzoglou, Gregory Kourakli. Targeting the Endocannabinoid System: From the Need for New Therapies to the Development of a Promising Strategy. What About Pancreatic Cancer? In vivo (Athens, Greece). vol 36. issue 2. 2022-03-04. PMID:35241505. |
cannabinoids, the active components of cannabis sativa l., and their derivatives, have been reported as palliative adjuvants to conventional chemotherapeutic regimens. |
2022-03-04 |
2023-08-13 |
Not clear |
| Daniele Piomelli, Robert Solomon, Donald Abrams, Agnes Balla, Igor Grant, Thomas Marcotte, John Yode. Regulatory Barriers to Research on Cannabis and Cannabinoids: A Proposed Path Forward. Cannabis and cannabinoid research. vol 4. issue 1. 2022-03-03. PMID:35236017. |
regulatory barriers to research on cannabis and cannabinoids: a proposed path forward. |
2022-03-03 |
2023-08-13 |
Not clear |
| Alexander Jordan, Ali Sherazi, Andrew J Flewelling, Victoria Northrup, Ather Naseemuddin, Jennifer L She. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization. The International journal on drug policy. vol 103. 2022-03-01. PMID:35228057. |
identification of cannabinoids in post-mortem blood samples from the province of new brunswick before and after recreational cannabis legalization. |
2022-03-01 |
2023-08-13 |
Not clear |
| Alexander Jordan, Ali Sherazi, Andrew J Flewelling, Victoria Northrup, Ather Naseemuddin, Jennifer L She. Identification of cannabinoids in post-mortem blood samples from the province of New Brunswick before and after recreational cannabis legalization. The International journal on drug policy. vol 103. 2022-03-01. PMID:35228057. |
given the immediate availability of cannabis in nb after legalization, we sought to establish the effect this had on post-mortem cannabinoid detection. |
2022-03-01 |
2023-08-13 |
Not clear |
| Sara Casati, Ilaria Angeli, Roberta F Bergamaschi, Alessandro Ravelli, Gaia Colombo, Giorgio Binelli, Mauro Minoli, Marica Oriol. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use. Forensic science international. vol 333. 2022-03-01. PMID:35228140. |
determination of cannabinoids in hair: indicators for illegal vs cbd-rich cannabis use. |
2022-03-01 |
2023-08-13 |
Not clear |
| Sara Casati, Ilaria Angeli, Roberta F Bergamaschi, Alessandro Ravelli, Gaia Colombo, Giorgio Binelli, Mauro Minoli, Marica Oriol. Determination of cannabinoids in hair: Indicators for illegal vs CBD-rich cannabis use. Forensic science international. vol 333. 2022-03-01. PMID:35228140. |
in this paper, which aims to establish alternative discrimination parameters between hair samples from cbd-rich and thc-prevalent cannabis users, cannabinoid concentrations, such as thc, cbd, 11-nor-9-carboxy-Δ9-tetrahydrocannabinol (thc-cooh) and 11-hydroxy-Δ9-tetrahydrocannabinol (11-oh-thc) were quantified in 127 hair samples by a gc-ms/ms technique. |
2022-03-01 |
2023-08-13 |
Not clear |